4174.TWO
Price:
$27.65
Market Cap:
$7.27B
OBI Pharma, Inc., a biopharma company, develops and licenses novel therapeutic agents for unmet medical needs against cancer in Taiwan and internationally. It offers Adagloxad Simolenin (OBI-822), a breast cancer active immunity anti-cancer drug for generating antibody against tumor carbohydrate antigen Globo H; OBI-833, an immunity anti-cancer drug for the treatment of lung cancer; OBI-866 SSEA-4, an active immune-oncology drug; OBI-888, a passive immunotherapy monoclonal antibody designed for targeting Globo H; OBI-999, an antibody drug conjugate; OBI-3424, a micromolecule chemotherapy prodrug; and OBI-858, a botulinum toxin, as well as OBI-898 and OBI-998 drugs. The company was founded in...[Read more]
Industry
Biotechnology
IPO Date
2012-12-12
Stock Exchange
TWO
Ticker
4174.TWO
According to OBI Pharma, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 6.67B. This represents a change of -49.92% compared to the average of 13.33B of the last 4 quarters.
The mean historical Enterprise Value of OBI Pharma, Inc. over the last ten years is 30.26B. The current 6.67B Enterprise Value has changed 2.11% with respect to the historical average. Over the past ten years (40 quarters), 4174.TWO's Enterprise Value was at its highest in in the December 2015 quarter at 106.79B. The Enterprise Value was at its lowest in in the June 2025 quarter at 8.02B.
Average
30.26B
Median
21.51B
Minimum
10.76B
Maximum
105.98B
Discovering the peaks and valleys of OBI Pharma, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 95.52%
Maximum Annual Enterprise Value = 105.98B
Minimum Annual Increase = -55.68%
Minimum Annual Enterprise Value = 10.76B
| Year | Enterprise Value | Change |
|---|---|---|
| 2024 | 12.44B | -19.38% |
| 2023 | 15.43B | 43.32% |
| 2022 | 10.76B | -47.04% |
| 2021 | 20.33B | -16.49% |
| 2020 | 24.34B | 17.06% |
| 2019 | 20.79B | -6.46% |
| 2018 | 22.23B | -4.56% |
| 2017 | 23.29B | -50.42% |
| 2016 | 46.97B | -55.68% |
| 2015 | 105.98B | 95.52% |
The current Enterprise Value of OBI Pharma, Inc. (4174.TWO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
12.88B
5-year avg
16.66B
10-year avg
30.26B
OBI Pharma, Inc.’s Enterprise Value is greater than Formosa Pharmaceuticals, Inc. (3.82B), less than TaiGen Biopharmaceuticals Holdings Limited (8.85B), greater than Pharmosa Biopharm Inc. (6.54B), greater than BRIM Biotechnology, Inc. (3.11B), less than Mycenax Biotech Inc. (7.42B), greater than CHO Pharma, Inc. (5.87B), greater than Savior Lifetec Corporation (4.26B), greater than Sinphar Pharmaceutical Co.,Ltd. (6.58B), greater than Panion & Bf Biotech Inc. (5.75B), less than PharmaEngine, Inc. (7.72B),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 3.82B | $4.02B | |
| 8.85B | $8.83B | |
| 6.54B | $7.15B | |
| 3.11B | $3.85B | |
| 7.42B | $6.52B | |
| 5.87B | $6.01B | |
| 4.26B | $5.43B | |
| 6.58B | $5.80B | |
| 5.75B | $5.49B | |
| 7.72B | $10.49B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like OBI Pharma, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like OBI Pharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is OBI Pharma, Inc.'s Enterprise Value?
What is the highest Enterprise Value for OBI Pharma, Inc. (4174.TWO)?
What is the 3-year average Enterprise Value for OBI Pharma, Inc. (4174.TWO)?
What is the 5-year average Enterprise Value for OBI Pharma, Inc. (4174.TWO)?
How does the current Enterprise Value for OBI Pharma, Inc. (4174.TWO) compare to its historical average?